VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BBIO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BBIOBridgeBio Pharma, Inc.
$77.91$15.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksBBIOQuarterly Financials

BridgeBio Pharma, Inc. (BBIO) Quarterly Financials

120+ quarters historyFree accessUpdated daily

BridgeBio Pharma, Inc. (BBIO) quarterly income statement — complete revenue, gross profit & net income history

BBIO Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue194.51M154.18M120.7M110.56M116.63M5.88M2.73M2.17M211.12M1.75M4.09M1.64M1.83M1.87M338K73.75M1.69M12.89M2.34M54.02M
Revenue Growth %66.78%2521.22%4318.01%4999.86%-44.76%237.08%-33.22%32.11%11461.88%-6.68%1110.36%-97.77%7.79%-85.49%-85.58%36.51%266.67%10462.3%-71.16%-
Cost of Goods Sold10.43M15.42M6.56M3.65M2.64M2.08M598K598K598K598K598K599K651K647K739K700K1.35M1.55M1.45M109K
COGS % of Revenue5.36%10%5.44%3.3%2.26%35.43%21.89%27.58%0.28%34.27%14.62%36.5%35.65%34.6%218.64%0.95%79.57%12.04%62.03%0.2%
Gross Profit184.09M138.76M114.14M106.91M113.99M3.8M2.13M1.57M210.52M1.15M3.49M1.04M1.18M1.22M-401K73.05M346K11.34M890K53.91M
Gross Margin %94.64%90%94.56%96.7%97.74%64.57%78.11%72.42%99.72%65.73%85.38%63.5%64.35%65.4%-118.64%99.05%20.42%87.96%37.97%99.8%
Gross Profit Growth %61.49%3553.55%5248.5%6709.68%-45.85%231.12%-38.91%50.67%17816.77%-6.21%971.07%-98.57%239.6%-89.21%-145.06%35.48%-25.11%9190.98%-89.05%-
Operating Expenses290.05M324M259.34M241.19M218.37M229.82M193.88M177.11M210.18M178.56M161.19M147.14M127.34M130.46M128.72M153.22M174.02M176.95M150.39M147.93M
OpEx % of Revenue149.11%210.14%214.86%218.14%187.22%3907.26%7096.78%8169.23%99.55%10232.84%3939.99%8966.54%6973.6%6976.2%38081.36%207.77%10272.96%1373.19%6415.91%273.82%
Selling, General & Admin163.9M182M137.62M129.15M106.36M94.78M68.82M59.52M65.81M47.58M35.78M36.12M31.11M31.86M31.19M36.43M43.71M54.75M46.08M45.97M
SG&A % of Revenue84.26%118.04%114.02%116.81%91.2%1611.39%2519%2745.53%31.17%2726.82%874.53%2201.22%1703.61%1703.85%9227.22%49.39%2580.46%424.87%1966.04%85.09%
Research & Development126.64M142M112.87M111.23M111.43M130.35M120.44M114.69M140.97M130.23M125.14M107.49M92.86M90.9M92.51M108.4M107.65M122.2M104.31M101.96M
R&D % of Revenue65.1%92.1%93.52%100.6%95.54%2216.08%4408.64%5290.36%66.77%7462.81%3058.81%6550.15%5085.49%4861.07%27370.12%146.99%6354.72%948.32%4449.87%188.73%
Other Operating Expenses-486K01000K805K570K1000K1000K1000K1000K754K272K1000K1000K1000K1000K1000K1000K000
Operating Income-105.96M-185.24M-145.2M-134.28M-104.37M-226.03M-191.75M-175.54M343K-177.42M-157.69M-146.1M-126.16M-129.23M-129.12M-80.18M-173.68M-165.61M-149.5M-94.02M
Operating Margin %-54.47%-120.14%-120.3%-121.45%-89.49%-3842.69%-7018.67%-8096.82%0.16%-10167.11%-3854.61%-8903.05%-6909.26%-6910.8%-38200%-108.72%-10252.54%-1285.22%-6377.94%-174.02%
Operating Income Growth %-1.52%18.05%24.28%23.51%-30529.15%-27.4%-21.6%-20.15%100.27%-37.28%-22.13%-82.22%27.36%21.97%13.63%14.72%-3.69%-29.9%-24.65%24.53%
EBITDA-104.77M-180.24M-143.8M-132.96M-103.09M-224.66M-190.21M-173.97M1.94M-175.83M-156.05M-144.46M-124.53M-127.57M-127.47M-78.59M-171.79M-164.09M-149.23M-90.53M
EBITDA Margin %-53.86%-116.9%-119.14%-120.26%-88.39%-3819.45%-6962.37%-8024.22%0.92%-10076.28%-3814.54%-8803.29%-6819.82%-6822.03%-37713.31%-106.57%-10141.32%-1273.38%-6366.64%-167.57%
EBITDA Growth %-1.63%19.77%24.4%23.57%-5416.55%-27.77%-21.89%-20.42%101.56%-37.83%-22.42%-83.81%27.51%22.25%14.58%13.18%-2.91%-29.15%-24.78%26.44%
D&A (Non-Cash Add-back)1.19M5M1.4M1.32M1.28M1.37M1.54M1.57M1.6M1.58M1.64M1.64M1.63M1.66M1.65M1.58M1.88M1.53M265K3.49M
EBIT-105.96M-185.24M-174.74M-144.02M-127.47M-236.41M-141.19M-52.61M-12.69M-150.06M-159.18M-140.11M-122.61M-120.58M-120.37M17.72M-180.99M-137.15M-149.95M-91.23M
Net Interest Income-46.57M-7.67M-5.5M-33.74M-36.76M-25.14M-19.77M-17.74M-19.4M-14.69M-16.51M-16.08M-15.97M-15.9M-17.41M-19.51M-20.08M-14.95M-10.83M-10.52M
Interest Income6.25M4.33M6.24M3.9M5.38M4.68M3.3M5.2M4.08M5.58M3.79M4.51M4.15M4.09M2.42M766K267K182K234K323K
Interest Expense52.81M12M11.74M37.64M42.14M29.82M23.06M22.94M23.47M20.27M20.31M20.59M20.12M19.99M19.82M20.28M20.34M15.13M11.07M10.84M
Other Income/Expense-60.6M-12M-41.28M-47.38M-65.24M-40.21M27.5M100M-36.5M7.09M-21.8M-14.6M-16.57M-11.34M-11.08M77.62M-27.65M13.33M-11.52M-8.06M
Pretax Income-166.56M-197.24M-186.48M-181.66M-169.61M-266.24M-164.25M-75.54M-36.16M-170.33M-179.49M-160.7M-142.73M-140.57M-140.19M-2.56M-201.33M-152.28M-161.02M-102.07M
Pretax Margin %-85.63%-127.93%-154.5%-164.3%-145.42%-4526.28%-6012.23%-3484.5%-17.13%-9760.92%-4387.39%-9792.99%-7816.65%-7517.11%-41477.22%-3.47%-11884.89%-1181.76%-6869.28%-188.94%
Income Tax00-1.54M2.1M01.15M00000000000000
Effective Tax Rate %0%0%0.83%-1.16%0%-0.43%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-164.04M-197.24M-182.74M-181.9M-167.42M-265.05M-162.04M-73.46M-35.22M-168.15M-177M-157.9M-140.16M-137.59M-137.34M-9.86M-196.4M-147.18M-155.94M-96.35M
Net Margin %-84.33%-127.93%-151.4%-164.52%-143.55%-4506.12%-5931.19%-3388.19%-16.68%-9635.99%-4326.55%-9622.12%-7675.58%-7357.81%-40632.84%-13.36%-11593.68%-1142.15%-6652.52%-178.34%
Net Income Growth %2.02%25.58%-12.78%-147.64%-375.41%-57.63%8.45%53.48%74.87%-22.21%-28.88%-1502.06%28.64%6.51%11.93%89.77%-20.43%-22.67%-34.59%20.4%
Net Income (Continuing)-166.56M-197.24M-184.94M-183.76M-169.61M-267.39M-164.25M-75.54M-36.16M-170.33M-179.49M-160.7M-142.73M-140.57M-140.19M-2.56M-201.33M-152.28M-161.02M-102.07M
Discontinued Operations00000000000000000000
Minority Interest-951K-570K10.34M9.44M9.73M10.29M11.53M10.83M12.67M11.72M13.81M12.38M12.05M9.69M8.04M10.52M309K4.83M7.52M8.67M
EPS (Diluted)-0.84-1.00-0.96-0.95-0.88-1.40-0.86-0.39-0.20-0.96-1.08-0.98-0.92-1.04-1.00-0.07-1.35-1.01-1.06-0.66
EPS Growth %4.55%28.57%-11.63%-143.59%-340%-45.83%20.37%60.2%78.26%7.69%-8%-1358.33%31.85%-2.97%5.66%89.82%-14.41%0%-8.16%35.92%
EPS (Basic)-0.84-1.00-0.96-0.95-0.88-1.40-0.86-0.39-0.20-0.96-1.08-0.98-0.92-1.04-1.00-0.07-1.35-1.01-1.06-0.66
Diluted Shares Outstanding194.79M197.24M190.52M190.52M190.15M189.44M188.51M187.59M178.71M174.46M163.31M160.54M152.65M149.34M147.94M146.68M145.88M145.28M146.66M146.75M
Basic Shares Outstanding194.79M197.24M190.52M190.52M190.15M189.44M188.51M187.59M178.71M174.46M163.31M160.54M152.65M149.34M147.94M146.68M145.88M145.28M146.66M146.75M
Dividend Payout Ratio--------------------